Brejjette Aljabi
Papers
2
Total Citations
4
H-Index
2
About
Brejjette Aljabi is a leading surgical oncologist whose research is reshaping the treatment of advanced renal cell carcinoma (RCC), particularly in cases involving tumor thrombus. Her work focuses on comparing the efficacy and outcomes of open, laparoscopic, and robotic surgical approaches for cytoreductive nephrectomy and tumor thrombectomy. Aljabi’s major contributions include landmark studies from the Intercontinental Collaboration on Renal Cell Carcinoma, which systematically evaluate overall survival and perioperative outcomes across these three techniques. Her 2025 papers, each garnering 2 citations, provide critical evidence that helps surgeons select the optimal approach for complex RCC with tumor thrombus—a challenging condition requiring high-risk, multidisciplinary management. By quantifying the trade-offs between minimally invasive and open surgery, Aljabi’s research directly informs clinical decision-making and patient counseling. Her work is foundational for urologic oncologists seeking to balance oncologic control with surgical morbidity, and it positions her as a key voice in the ongoing evolution of surgical standards for metastatic RCC.
Research Focus
Key Achievements
Top Papers
- 1
- 2